Medicared For All Logo

Justyna Watkowska MD in New York, New York

Home New York New York

Justyna Watkowska MD has Nuclear Medicine as her primary medical specialty. Their primary office is: 111 Broadway in New York, New York. There is an additional office location, for a total of two, for Justyna Watkowska MD that can be viewed further down.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-9700 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1987 (around 37 years of experience). They are listed as doing telehealth appointments.


Justyna Watkowska MD Office Phone and Directions

Justyna Watkowska MD
New York University
111 Broadway
New York, New York 10006
212-263-9700


Patient Ratings
Please rate your experience with Justyna Watkowska MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 212-263-9700


Enter a starting address:


Healthcare Info for Justyna Watkowska MD

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY)

Medical School: Sorry, her university is not listed
Graduation Year: 1987
The Primary Medical Specialty for Justyna Watkowska MD is listed as: Nuclear Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 7810978061
NPI #: 1881666097
NPI Created On: 02/02/2006
NPI Last Updated Listed as: 04/02/2021
Primary Taxonomy Code: 207RC0000X
License Number:
43817
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  3. Routine ekg using at least 12 leads including interpretation and report
  4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
  5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
  6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
  7. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
  8. Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days
  9. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  10. New patient office or other outpatient visit, typically 45 minutes
  11. Established patient office or other outpatient visit, typically 15 minutes
  12. Established patient office or other outpatient, visit typically 25 minutes
  13. Established patient office or other outpatient, visit typically 40 minutes
  14. Physician telephone patient service, 11-20 minutes of medical discussion
  15. Physician telephone patient service, 21-30 minutes of medical discussion
  16. Technetium tc-99m sestamibi, diagnostic, per study dose
  17. Injection, regadenoson, 0.1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 816102209

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 816111731

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 816119797

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783664241

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783664251

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783664257

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783664267

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783664273

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783664277

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $33

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768811132

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest


Additional Office Locations

1. New York University
1220 Ave P
Brooklyn, NY 11229
Group Members: 4,291

Phone: 212-263-9700

Enter a starting address:


Nuclear Medicine Professionals in New York

61 E 77th St
New-york, NY
Lenox Hill Radiology And Medical Imaging Associates Pc

622 W 168th St
New-york, NY
Trustees Of Columbia University In The City Of New York

1275 York Ave
New-york, NY
Memorial Nuclear Medicine Group

225 E 126th St
New-york, NY
The New York Proton Center

325 W 15th St
New-york, NY
Fpa Hospital Based

1111 Amsterdam Ave
New-york, NY
Fpa Hospital Based

Providers in New York University

1.Jennifer Abate

240 E 38th St
New York Ny 10016-2708
New York University
Nurse Practitioner

2.Nabil Abazaid

111 Broadway
New York Ny 10006-1901
New York University
Emergency Medicine

3.Valentino Abballe

16 Th St And 1st Ave
New York Ny 10003-3804
New York University
Diagnostic Radiology

4.Valentino Abballe

301 E 17th St
New York Ny 10003-3804
New York University
Diagnostic Radiology

5.Valentino Abballe

111 Broadway
New York Ny 10006-1901
New York University
Diagnostic Radiology

6.Valentino Abballe

111 Broadway
New York Ny 10006-1995
New York University
Diagnostic Radiology

View all 4,291 members of New York University medical group